Cargando…
An Oral Formulation of the Probiotic, Bacillus subtilis HU58, Was Safe and Well Tolerated in a Pilot Study of Patients with Hepatic Encephalopathy
BACKGROUND: Hepatic encephalopathy often results in high blood ammonia levels because of inefficient ammonia processing by the liver. Lactulose treatment promotes the growth of urease-producing gut bacteria and a reduced colon pH, thus reducing blood ammonia absorption. It is thought that probiotics...
Autores principales: | Yossef, Sayed, Clark, Frances, Bubeck, Sarah S., Abernethy, John, Bayne, Thomas, Krishnan, Kiran, Young, Aicacia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345602/ https://www.ncbi.nlm.nih.gov/pubmed/32714397 http://dx.doi.org/10.1155/2020/1463108 |
Ejemplares similares
-
Bacillus subtilis HU58 and Bacillus coagulans SC208 Probiotics Reduced the Effects of Antibiotic-Induced Gut Microbiome Dysbiosis in an M-SHIME(®) Model
por: Marzorati, Massimo, et al.
Publicado: (2020) -
Bacillus licheniformis and Bacillus subtilis, Probiotics That Induce the Formation of Macrophage Extracellular Traps
por: Romo-Barrera, Carol M., et al.
Publicado: (2021) -
New crosstalk between probiotics Lactobacillus plantarum and Bacillus subtilis
por: Yu, Tao, et al.
Publicado: (2019) -
The Impact of Probiotic Bacillus subtilis on Injurious Behavior in Laying Hens
por: Jiang, Sha, et al.
Publicado: (2022) -
Bacillus
subtilis isolates from camel milk as probiotic candidates
por: Daneshazari, Roya, et al.
Publicado: (2023)